Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Antimicrobial Proteins01:23

Antimicrobial Proteins

887
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
887

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A lipoprotein partner for the <i>Escherichia coli</i> outer membrane protein TolC.

eLife·2026
Same author

Syk activation during FcγR-mediated phagocytosis involves Syk palmitoylation and desulfenylation.

Life science alliance·2026
Same author

Targeting bacterial kinases as a strategy to counteract antibiotic resistance.

Communications chemistry·2025
Same author

Fragment-based drug design of a bacterial kinase inhibitor capable of increasing the antibiotic sensitivity of clinical isolates.

Communications chemistry·2025
Same author

An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMP.

Science advances·2025
Same author

Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study.

Biomolecules·2025

Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

528

APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus.

Elise Kaplan1,2, Laurent Chaloin1, Jean-François Guichou3

  • 1Institut de Recherche en Infectiologie de Montpellier - IRIM, University of Montpellier, CNRS UMR 9004, 1919 route de Mende, 34293, Montpellier cedex 5, France.

Chemmedchem
|January 13, 2025
PubMed
Summary

Researchers discovered small molecules that counteract bacterial aminoglycoside resistance. One compound, EK3, non-competitively inhibits a key enzyme, restoring antibiotic effectiveness against resistant bacteria without toxicity.

Keywords:
AllosteryAntibiotic resistanceInhibitorsMolecular dockingVirtual screening

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

10.7K
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.7K

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

528
Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

10.7K
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.7K

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Aminoglycoside-phosphotransferases (APHs) confer bacterial resistance to aminoglycoside antibiotics.
  • Acquired APH-mediated resistance poses a significant clinical challenge, necessitating novel therapeutic strategies.
  • Enterococcus casseliflavus is a relevant model for studying antibiotic resistance mechanisms.

Purpose of the Study:

  • To identify small molecules that counteract aminoglycoside resistance mediated by APH enzymes.
  • To explore the potential of allosteric modulators as a strategy against antibiotic resistance.
  • To validate in silico screening methods for drug discovery.

Main Methods:

  • In silico screening of 12,000 small molecules using molecular dynamics simulations to identify allosteric pockets in APH enzymes.
  • In vitro testing of high-scored compounds for enzymatic inhibition.
  • Structure-activity relationship (SAR) studies to optimize lead compounds.
  • Bacterial sensitivity assays and cytotoxicity tests on HeLa cells.

Main Results:

  • Identification of EK3, a non-competitive inhibitor of APH(2'')-IVa, an enzyme conferring gentamicin resistance.
  • Optimization of EK3 through SAR studies yielded compounds with improved enzymatic inhibition.
  • The best compounds restored the bactericidal activity of multiple aminoglycosides against resistant bacteria.
  • No observed toxicity in HeLa cells for the most effective compounds.

Conclusions:

  • Small molecules can effectively counteract APH-mediated aminoglycoside resistance.
  • Allosteric inhibition of APH enzymes is a viable strategy for developing new antibiotics.
  • In silico drug discovery methods can accelerate the identification of novel antibacterial agents.
  • This study provides a foundation for developing new treatments against aminoglycoside-resistant bacterial infections.